Carboxylic modified spherical mesoporous silicas s drug delivery carriers

Margarita D. Popova, A. Szegedi, Iliyan N. Kolev, J. Mihály, Borislav S. Tzankov, Georgi Tz Momekov, Nikolai G. Lambov, Krassimira P. Yoncheva

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The present study deals with the development and functionalization of mesoporous silica nanoparticles as drug delivery platforms. Spherical MCM-41 and SBA-15 silicas with different pore sizes (2.7 nm and 5.5 nm, respectively) were post-synthesis modified applying a new, two step process. The initial step was the modification with 3-amino-propyltriethoxysilane, and the next was the reaction with succinic anhydride in toluene in order to obtain carboxylic modified mesoporous carriers. The carboxylic-functionalized mesoporous materials were characterized by XRD, nitrogen physisorption, TEM, ATR FT-IR spectroscopy. The successful carboxylic functionalization was proved by the changes of the zeta potential of the mesoporous materials before and after modification. The parent and the carboxylic-modified MCM-41 and SBA-15 materials showed high adsorption capacity (approximately 50 wt.%, except for non-functionalized MCM-41) for sulfadiazine that possesses amino functional groups. Mesoporous structure peculiarities lead to different adsorption capacities on the carriers. In vitro release studies showed slower release rate of sulfadiazine from carboxylic modified MCM-41 and SBA-15 mesoporous particles compared to the non modified ones. Both non loaded and drug-loaded silica materials demonstrated no cytotoxicity on Caco-2 cell line. The functionalized mesoporous systems are appropriate drug delivery platforms due to their biocompatibility and the possibility to modify drug release.

Original languageEnglish
Pages (from-to)778-785
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume436
Issue number1-2
DOIs
Publication statusPublished - Oct 15 2012

Fingerprint

Drug Carriers
Silicon Dioxide
Sulfadiazine
Adsorption
Caco-2 Cells
Toluene
Drug Delivery Systems
Pharmaceutical Preparations
Nanoparticles
Spectrum Analysis
Nitrogen
Cell Line
MCM-41
SBA-15

Keywords

  • Carboxylic modification
  • Drug release
  • Spherical mesoporous silica
  • Sulfadiazine

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Carboxylic modified spherical mesoporous silicas s drug delivery carriers. / Popova, Margarita D.; Szegedi, A.; Kolev, Iliyan N.; Mihály, J.; Tzankov, Borislav S.; Momekov, Georgi Tz; Lambov, Nikolai G.; Yoncheva, Krassimira P.

In: International Journal of Pharmaceutics, Vol. 436, No. 1-2, 15.10.2012, p. 778-785.

Research output: Contribution to journalArticle

Popova, Margarita D. ; Szegedi, A. ; Kolev, Iliyan N. ; Mihály, J. ; Tzankov, Borislav S. ; Momekov, Georgi Tz ; Lambov, Nikolai G. ; Yoncheva, Krassimira P. / Carboxylic modified spherical mesoporous silicas s drug delivery carriers. In: International Journal of Pharmaceutics. 2012 ; Vol. 436, No. 1-2. pp. 778-785.
@article{1f1bff0692354905a54335c897a94de2,
title = "Carboxylic modified spherical mesoporous silicas s drug delivery carriers",
abstract = "The present study deals with the development and functionalization of mesoporous silica nanoparticles as drug delivery platforms. Spherical MCM-41 and SBA-15 silicas with different pore sizes (2.7 nm and 5.5 nm, respectively) were post-synthesis modified applying a new, two step process. The initial step was the modification with 3-amino-propyltriethoxysilane, and the next was the reaction with succinic anhydride in toluene in order to obtain carboxylic modified mesoporous carriers. The carboxylic-functionalized mesoporous materials were characterized by XRD, nitrogen physisorption, TEM, ATR FT-IR spectroscopy. The successful carboxylic functionalization was proved by the changes of the zeta potential of the mesoporous materials before and after modification. The parent and the carboxylic-modified MCM-41 and SBA-15 materials showed high adsorption capacity (approximately 50 wt.{\%}, except for non-functionalized MCM-41) for sulfadiazine that possesses amino functional groups. Mesoporous structure peculiarities lead to different adsorption capacities on the carriers. In vitro release studies showed slower release rate of sulfadiazine from carboxylic modified MCM-41 and SBA-15 mesoporous particles compared to the non modified ones. Both non loaded and drug-loaded silica materials demonstrated no cytotoxicity on Caco-2 cell line. The functionalized mesoporous systems are appropriate drug delivery platforms due to their biocompatibility and the possibility to modify drug release.",
keywords = "Carboxylic modification, Drug release, Spherical mesoporous silica, Sulfadiazine",
author = "Popova, {Margarita D.} and A. Szegedi and Kolev, {Iliyan N.} and J. Mih{\'a}ly and Tzankov, {Borislav S.} and Momekov, {Georgi Tz} and Lambov, {Nikolai G.} and Yoncheva, {Krassimira P.}",
year = "2012",
month = "10",
day = "15",
doi = "10.1016/j.ijpharm.2012.07.061",
language = "English",
volume = "436",
pages = "778--785",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Carboxylic modified spherical mesoporous silicas s drug delivery carriers

AU - Popova, Margarita D.

AU - Szegedi, A.

AU - Kolev, Iliyan N.

AU - Mihály, J.

AU - Tzankov, Borislav S.

AU - Momekov, Georgi Tz

AU - Lambov, Nikolai G.

AU - Yoncheva, Krassimira P.

PY - 2012/10/15

Y1 - 2012/10/15

N2 - The present study deals with the development and functionalization of mesoporous silica nanoparticles as drug delivery platforms. Spherical MCM-41 and SBA-15 silicas with different pore sizes (2.7 nm and 5.5 nm, respectively) were post-synthesis modified applying a new, two step process. The initial step was the modification with 3-amino-propyltriethoxysilane, and the next was the reaction with succinic anhydride in toluene in order to obtain carboxylic modified mesoporous carriers. The carboxylic-functionalized mesoporous materials were characterized by XRD, nitrogen physisorption, TEM, ATR FT-IR spectroscopy. The successful carboxylic functionalization was proved by the changes of the zeta potential of the mesoporous materials before and after modification. The parent and the carboxylic-modified MCM-41 and SBA-15 materials showed high adsorption capacity (approximately 50 wt.%, except for non-functionalized MCM-41) for sulfadiazine that possesses amino functional groups. Mesoporous structure peculiarities lead to different adsorption capacities on the carriers. In vitro release studies showed slower release rate of sulfadiazine from carboxylic modified MCM-41 and SBA-15 mesoporous particles compared to the non modified ones. Both non loaded and drug-loaded silica materials demonstrated no cytotoxicity on Caco-2 cell line. The functionalized mesoporous systems are appropriate drug delivery platforms due to their biocompatibility and the possibility to modify drug release.

AB - The present study deals with the development and functionalization of mesoporous silica nanoparticles as drug delivery platforms. Spherical MCM-41 and SBA-15 silicas with different pore sizes (2.7 nm and 5.5 nm, respectively) were post-synthesis modified applying a new, two step process. The initial step was the modification with 3-amino-propyltriethoxysilane, and the next was the reaction with succinic anhydride in toluene in order to obtain carboxylic modified mesoporous carriers. The carboxylic-functionalized mesoporous materials were characterized by XRD, nitrogen physisorption, TEM, ATR FT-IR spectroscopy. The successful carboxylic functionalization was proved by the changes of the zeta potential of the mesoporous materials before and after modification. The parent and the carboxylic-modified MCM-41 and SBA-15 materials showed high adsorption capacity (approximately 50 wt.%, except for non-functionalized MCM-41) for sulfadiazine that possesses amino functional groups. Mesoporous structure peculiarities lead to different adsorption capacities on the carriers. In vitro release studies showed slower release rate of sulfadiazine from carboxylic modified MCM-41 and SBA-15 mesoporous particles compared to the non modified ones. Both non loaded and drug-loaded silica materials demonstrated no cytotoxicity on Caco-2 cell line. The functionalized mesoporous systems are appropriate drug delivery platforms due to their biocompatibility and the possibility to modify drug release.

KW - Carboxylic modification

KW - Drug release

KW - Spherical mesoporous silica

KW - Sulfadiazine

UR - http://www.scopus.com/inward/record.url?scp=84865764263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865764263&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2012.07.061

DO - 10.1016/j.ijpharm.2012.07.061

M3 - Article

VL - 436

SP - 778

EP - 785

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -